Investigating biomarkers of Staphylococcus aureus bacteremia in patients - School of Pharmacy

The Centers for Disease Control identifies methicillin-resistant S. aureus (MRSA) as a serious health threat with greater than 100,000 invasive infections and 20,000 patient deaths annually in the United States. Despite recent advancements in available treatment options for methicillin-sensitive S.

Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial

Timing of follow-up blood cultures for community-onset bacteremia

Bloodstream infections in critically ill patients: an expert statement

Methicillin-resistant Staphylococcus aureus: novel treatment approach breakthroughs, Bulletin of the National Research Centre

Antimicrobial resistance - Wikipedia

Estimation of Activity of CD14 Biomarker in Iraqi Burn Patients

B.I.G. Summer 2023 – Institute for Quantitative and Computational Biosciences

Redefining Staphylococcus aureus bacteremia: A structured approach guiding diagnostic and therapeutic management - ScienceDirect

Frontiers Management of Staphylococcus aureus Bloodstream Infections

JCI Insight - Protection against Staphylococcus aureus bacteremia–induced mortality depends on ILC2s and eosinophils